Dehydrocorydaline attenuates bleomycin-induced pulmonary fibrosis by inhibiting fibroblast activation
Abstract Background Pulmonary fibrosis (PF) is an irreversible, progressive, chronic and fatal interstitial lung disease with limited therapeutic options. Dehydrocorydaline (DHC), derived from the traditional Chinese medicinal plant Corydalis yanhusuo, has exhibited a variety of pharmacological prop...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2025-04-01
|
| Collection: | Respiratory Research |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12931-025-03218-5 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
